Treating Urothelial Bladder Cancer

This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the dise...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Format: Elektronisch E-Book
Sprache:Englisch
Veröffentlicht: Cham : Springer International Publishing, 2018.
Ausgabe:1st ed. 2018.
Schlagworte:
ISBN:9783319785592
Online-Zugang: Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a22000005i 4500
003 SK-BrCVT
005 20220618102240.0
007 cr nn 008mamaa
008 180802s2018 gw | s |||| 0|eng d
020 |a 9783319785592 
024 7 |a 10.1007/978-3-319-78559-2  |2 doi 
035 |a CVTIDW14929 
040 |a Springer-Nature  |b eng  |c CVTISR  |e AACR2 
041 |a eng 
245 1 0 |a Treating Urothelial Bladder Cancer   |h [electronic resource] /  |c edited by Francesco Soria, Paolo Gontero. 
250 |a 1st ed. 2018. 
260 1 |a Cham :  |b Springer International Publishing,  |c 2018. 
300 |a VIII, 133 p. 25 illus., 18 illus. in color.  |b online resource. 
500 |a Medicine  
505 0 |a Preface -- Part I: Bladder cancer diagnosis -- Imaging and bladder cancer: can we do better? -- Optical improvements in bladder cancer diagnosis: seeing better for a better management -- Enhancing the quality of transurethral resection: the importance of a complete TURB and the en-bloc resection -- Active surveillance for low risk non-muscle invasive bladder cancer -- Part II: Non-muscle invasive bladder cancer -- How good we are to predict the outcomes of non-muscle invasive bladder cancer? -- Adjuvant treatment: old and new immunotherapy in non-muscle invasive bladder cancer -- The role of new experimental conservative therapies for high risk non-muscle invasive bladder cancer. Could we trust them? -- Part III: Muscle invasive bladder cancer -- Is there still a role for radical cystectomy? -- Minimally invasive radical cystectomy and its role in the treatment of bladder cancer patients. Myth or reality? -- Neoadjuvant vs adjuvant chemotherapy: which is right? -- Radiotherapy for the treatment of muscle invasive bladder cancer -- Immunotherapy and new combinations -- Part IV: A view on the future -- The role of urologist -- The role of pathologist -- The role of medical oncologist -- The role of radiotherapist. 
516 |a text file PDF 
520 |a This book aims to bring together the current research and discussions surrounding bladder cancer management. New technologies and therapeutic agents have become increasingly effective at treating urothelial bladder cancer and have created a range of opportunities to change the ways in which the disease is treated. Chapters cover the changes in adjuvant treatment, confocal laser endomicroscopy, and the roles of oncologists, pathologists, and radiotherapists in managing bladder cancer. Treating Urothelial Bladder Cancer is particularly relevant to urologists, oncologists, and radiotherapists, but is also applicable to practitioners, geriatricians, and public health managers due to its multidisciplinary approach to bladder cancer management. 
650 0 |a Urology. 
650 0 |a Oncology . 
650 0 |a Radiotherapy. 
856 4 0 |u http://hanproxy.cvtisr.sk/han/cvti-ebook-springer-eisbn-978-3-319-78559-2  |y Vzdialený prístup pre registrovaných používateľov 
910 |b ZE12209 
919 |a 978-3-319-78559-2 
974 |a andrea.lebedova  |f Elektronické zdroje 
992 |a SUD 
999 |c 239791  |d 239790